ACE2 - CHO Recombinant Cell Line
Recombinant clonal stable CHO cell line constitutively expressing full length human ACE2, Genbank #NM_021804.3). Surface expression of ACE2 was confirmed by flow cytometry.
This product has been cited 1 time.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
• Thaw Medium 3 (BPS Bioscience, #60186): Ham’s F-12 medium (Hyclone
#SH30526.01) supplemented with 10% FBS (Life technologies #26140-079), 1% Penicillin/Streptomycin (Hyclone #SV30010.01).
• Growth Medium 3J (BPS Bioscience, #79974): Thaw Medium 3 (BPS Bioscience, #60186) plus 5 μg/ml of Puromycin (Takara, #631306) to ensure recombinant expression.
• Spike (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) (BPS Bioscience, #79942)
• Bald lentiviral pseudovirion (Luciferase reporter) (BPS Bioscience, #79943)
• Anti-SARS-CoV-2 Spike antibody (clone AM001414, Active motif, #91361)
• Anti-ACE2 antibody (R&D systems, #AF933)
• Recombinant ACE2 protein (BPS Bioscience, #11003)
• 96-well tissue culture treated, white clear-bottom assay plate (Corning, #3610)
• ONE-Step™ luciferase assay system (BPS Bioscience, #60690)
This cell line has been screened using the MycoAlert™ Mycoplasma Detection Kit (Lonza, #LT07-118) to confirm the absence of Mycoplasma contamination.
Human Angiotensin converting enzyme 2 (ACE2), also known as ACEH, is an integral membrane protein found in the outer space of cells in the lungs, arteries, heart, kidney, and intestines. ACE2 serves as the entry point into cells for some coronaviruses, including the SARS-CoV-2 virus that is responsible for the COVID-19 pandemic.